The overall goal of this project is the determination of the three-dimensional structures of biologically active natural products bound to their macromolecular (protein) receptors. The structures are useful in defining the structure of the natural product, elucidating the mechanism by which the natural product acts, and serving as the first stage of a structure-based drug design cycle. The projects that were examined during the last period include: 1. Peptidyl-palmitoyl thioesterase (PPT) and didemnin. Didemnin is currently in phase II clinical trial for cancer, but it s mode of action is not known. PPT is an important signaling protein. 2. Trypsin and aeruginosin 98B. Trypsin is a surrogate target for more clinically relevant serine proteases such as thrombin. Aeruginosin 98B is an interesting target for drug design since it contains none of the standard serine protease inhibitory motifs and might therefore be expected to be more selective. 3. Cyclohexadienyl dehydratase (CDT) and prephenic acid. CDT is a key enzyme in the synthesis of the aromatic amino acid phenylalanine. Since it occurs only in bacterial, fungi and plants, it could be an important target for the design of antibacterial, antifungal, or herbicidal agents. 4. FK506 binding protein (FKBP12), FK506 rapamycin associated protein (FRAP) and rapamycin analogs. This project began as a study on the mechanism of action of the immunosuppressive agent rapamycin and has evolved into a study of rapamycin and some of its analogs as chemical inducers of dimerization (CID). Basically a CID is a small molecule that will join two proteins, and in the case we ve studied most extensively, the complex is FKBP12-rapamycin-FRB. Since CIDs can be used to control biological processes, such as gene therapy, it s important to get away from the completely natural system in order to avoid wild type targets. We re working on developing rapamycin analogs that won t bind to wild type FKBP12 and/or FRB and proteins (FKBP12 and/or FRB) with compensatory mutations.

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Biotechnology Resource Grants (P41)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cornell University
United States
Zip Code
Kozlov, Guennadi; Wong, Kathy; Gehring, Kalle (2018) Crystal structure of the Legionella effector Lem22. Proteins 86:263-267
Ménade, Marie; Kozlov, Guennadi; Trempe, Jean-François et al. (2018) Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations. J Biol Chem 293:12832-12842
Xu, Jie; Kozlov, Guennadi; McPherson, Peter S et al. (2018) A PH-like domain of the Rab12 guanine nucleotide exchange factor DENND3 binds actin and is required for autophagy. J Biol Chem 293:4566-4574
Dean, Dexter N; Rana, Pratip; Campbell, Ryan P et al. (2018) Propagation of an A? Dodecamer Strain Involves a Three-Step Mechanism and a Key Intermediate. Biophys J 114:539-549
Chen, Yu Seby; Kozlov, Guennadi; Fakih, Rayan et al. (2018) The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity. J Biol Chem 293:19998-20007
Xu, Caishuang; Kozlov, Guennadi; Wong, Kathy et al. (2016) Crystal Structure of the Salmonella Typhimurium Effector GtgE. PLoS One 11:e0166643
Cogliati, Massimo; Zani, Alberto; Rickerts, Volker et al. (2016) Multilocus sequence typing analysis reveals that Cryptococcus neoformans var. neoformans is a recombinant population. Fungal Genet Biol 87:22-9
Oot, Rebecca A; Kane, Patricia M; Berry, Edward A et al. (2016) Crystal structure of yeast V1-ATPase in the autoinhibited state. EMBO J 35:1694-706
Lucido, Michael J; Orlando, Benjamin J; Vecchio, Alex J et al. (2016) Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. Biochemistry 55:1226-38
Bauman, Joseph D; Harrison, Jerry Joe E K; Arnold, Eddy (2016) Rapid experimental SAD phasing and hot-spot identification with halogenated fragments. IUCrJ 3:51-60

Showing the most recent 10 out of 375 publications